ArticleFrontiers in pharmacology2022

Silibinin Therapy Improves Cholangiocarcinoma Outcomes by Regulating ERK/Mitochondrial Pathway.

Yang Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.